These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2541722)
1. Biochemical characterization of [3H]tryptamine binding sites from rat brain. BrĂ¼ning G; Rommelspacher H Biochem Int; 1989 Jan; 18(1):227-33. PubMed ID: 2541722 [TBL] [Abstract][Full Text] [Related]
2. [3H]tryptamine autoradiography in rat brain and choroid plexus reveals two distinct sites. Perry DC J Pharmacol Exp Ther; 1986 Feb; 236(2):548-59. PubMed ID: 3003349 [TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites. Nishimura SL; Recht LD; Pasternak GW Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950 [TBL] [Abstract][Full Text] [Related]
4. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain. Stratford CA; Tan GL; Hamblin MW; Ciaranello RD Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989 [TBL] [Abstract][Full Text] [Related]
5. [Interaction of the anxiolytic agent buspirone with serotonin and other synaptic receptors in the human brain]. Korneev AIa; Faktor MI; Chan TB Biull Eksp Biol Med; 1988 Jan; 105(1):41-3. PubMed ID: 2892547 [TBL] [Abstract][Full Text] [Related]
6. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain. Chow T; Zukin RS Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362 [TBL] [Abstract][Full Text] [Related]
7. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes. Itzhak Y; Hiller JM; Simon EJ Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930 [TBL] [Abstract][Full Text] [Related]
8. Effects of protein-modifying reagents on brain tryptamine binding sites: possible involvement of a thiol group in temperature-induced high-affinity [3H]tryptamine binding sites. Serikyaku S; Saito M; Ishitani R Jpn J Pharmacol; 1990 Jan; 52(1):51-7. PubMed ID: 1968519 [TBL] [Abstract][Full Text] [Related]
9. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. D'Amato RJ; Largent BL; Snowman AM; Snyder SH J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452 [TBL] [Abstract][Full Text] [Related]
10. Central and peripheral cocaine receptors. Calligaro DO; Eldefrawi ME J Pharmacol Exp Ther; 1987 Oct; 243(1):61-8. PubMed ID: 2822906 [TBL] [Abstract][Full Text] [Related]
11. Structural relationships in the inhibition of [3H]tryptamine binding to rat brain membranes in vitro by phenylalkylamines. Martin LL; Roland DM; Neale RF; Wood PL Eur J Pharmacol; 1986 Dec; 132(1):53-5. PubMed ID: 3816964 [TBL] [Abstract][Full Text] [Related]
12. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites. Kendall DA; Taylor DP; Enna SJ Mol Pharmacol; 1983 May; 23(3):594-9. PubMed ID: 6865906 [TBL] [Abstract][Full Text] [Related]
13. Multiple 3H-5-hydroxytryptamine binding sites in rat brain. Nelson DL; Pedigo NW; Yamamura HI J Physiol (Paris); 1981; 77(2-3):369-72. PubMed ID: 7288652 [TBL] [Abstract][Full Text] [Related]
14. The [3H]tryptamine receptor in human brain: kinetics, distribution, and pharmacologic profile. Mousseau DD; Butterworth RF J Neurochem; 1994 Sep; 63(3):1052-9. PubMed ID: 8051546 [TBL] [Abstract][Full Text] [Related]
15. Characterization of solubilized serotonin (S2) receptors in rat brain. Ilien B; Gorissen H; Laduron PM Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728 [TBL] [Abstract][Full Text] [Related]